Skip to main content

Advertisement

Log in

Valproic Acid: A Potential Therapeutic for Spinal Cord Injury

  • Review Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

The lack of an effective pharmaceutical agent for spinal cord injury (SCI) is a current problematic situation for clinicians, as the rate of motor vehicle accidents among young adults is on the rise. SCI contributes to the high disability rate. Presently, evidences detailing the precise pathological mechanisms in SCI are limited, compounding to the unavailability of an effective treatment method. Surgery, though not a complete curative method, is useful in managing some of the associated symptoms of secondary SCI. Autophagy and inflammation are contributive factors to both exacerbation and improvement of SCI. The mammalian target of rapamycin (mTOR) signaling pathway is a key player in the regulation of inflammatory response and autophagy. Valproic acid (VPA), a clinically used antiepileptic drug, has been suggested to improve neurological conditions, including SCI. This report reviewed the correlation between mTOR and autophagy, as well as autophagy’s role and the therapeutic effects of VPA in SCI. VPA regulates autophagy by potentially inhibiting mTORC1, a complex of mTOR, while also hindering inflammatory response. Conclusively, an effective treatment for SCI could lie in the timely regulation of mTOR signaling pathway, and VPA could be the potential drug that improves SCI owing to its propensity to regulate the mTOR signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

SCI:

Spinal cord injury

mTOR:

Mammalian target of rapamycin

BSCB:

Blood–spinal cord barrier

ER:

Endoplasmic reticulum

mTORC1:

Mammalian target of rapamycin complex 1

ATG13:

Autophagy-related protein 13

Ulk1:

Unc-51-like kinase 1

VPA:

Valproic acid

HDACI:

Histone deacetylase inhibitor

HDAC:

Histone deacetylase

mLST8:

Mammalian lethal with SEC13 protein 8

Raptor:

Regulatory protein associated with mTOR

FIP200:

Focal adhesion kinase family interacting protein of 200 kDa

TLR:

Toll-like receptors

NF-κB:

Nuclear factor kappa-light-chain-enhancer of activated B cells

AMPK:

5′ Adenosine monophosphate-activated protein kinase

PTEN:

Phosphatase and tensin homolog

SCG10:

Superior cervical ganglia protein 10

PI3K:

Phosphatidylinositol 3 kinase

PIP2:

Phosphatidylinositol 3,4-bisphosphate

PIP3:

Phosphatidylinositol 3,4,5-trisphosphate

SAHA:

Suberoylanilide hydroxamic acid

ALP:

Autophagy–lysosomal pathway

CNS:

Central nervous system

NSPCs:

Neural stem/progenitor cells

LC3-II:

Light chain 3-II

SOX2:

Sex determining region Y-box 2

Oct4:

Octamer-binding transcription factor 4

BDNF:

Brain-derived neurotrophic factor

TNF-α:

Tumor Necrosis Factor alpha

TGF:

Transforming growth factor

ALS:

Amyotrophic lateral sclerosis

MAP:

Mitogen-activated protein

JNK:

C-Jun N-terminal kinase

References

Download references

Funding

This work was supported by the Natural Science Foundation of Zhejiang Province (Grant No. LY19H170001).

Author information

Authors and Affiliations

Authors

Contributions

XL designed the study. CZ, SH, BOAB, YZ and XL prepared the first draft and revised the manuscript. All authors approved the final paper.

Corresponding author

Correspondence to Xuehong Liu.

Ethics declarations

Conflict of interest

The authors declare absence of competing interests.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

All authors agree to publish this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, C., Hu, S., Botchway, B.O.A. et al. Valproic Acid: A Potential Therapeutic for Spinal Cord Injury. Cell Mol Neurobiol 41, 1441–1452 (2021). https://doi.org/10.1007/s10571-020-00929-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-020-00929-9

Keywords

Navigation